Compare ELMD & EARN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ELMD | EARN |
|---|---|---|
| Founded | 1992 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 208.1M | 179.2M |
| IPO Year | 2010 | 2012 |
| Metric | ELMD | EARN |
|---|---|---|
| Price | $38.34 | $4.81 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 2 |
| Target Price | ★ $36.00 | $5.38 |
| AVG Volume (30 Days) | 59.1K | ★ 408.7K |
| Earning Date | 05-12-2026 | 06-16-2026 |
| Dividend Yield | N/A | ★ 20.51% |
| EPS Growth | ★ 46.55 | N/A |
| EPS | ★ 0.91 | N/A |
| Revenue | ★ $54,716,000.00 | N/A |
| Revenue This Year | $15.59 | $7.69 |
| Revenue Next Year | $11.51 | $19.57 |
| P/E Ratio | $41.89 | ★ N/A |
| Revenue Growth | ★ 13.83 | N/A |
| 52 Week Low | $17.73 | $4.27 |
| 52 Week High | $39.65 | $6.08 |
| Indicator | ELMD | EARN |
|---|---|---|
| Relative Strength Index (RSI) | 76.39 | 53.39 |
| Support Level | $23.47 | $4.54 |
| Resistance Level | N/A | $5.36 |
| Average True Range (ATR) | 2.37 | 0.09 |
| MACD | 0.99 | -0.01 |
| Stochastic Oscillator | 89.41 | 64.65 |
Electromed Inc is a United States-based company that develops, manufactures, markets, and sells products that provide airway clearance therapy, including the SmartVest Airway Clearance System and related products, to patients with compromised pulmonary function with a commitment to excellence and compassionate service. The SmartVest System features a programmable air pulse generator, a therapy garment worn over the upper body and a connecting hose, which together provide safe, comfortable, and effective airway clearance therapy.
Ellington Credit Co is focused on corporate collateralized loan obligations (CLOs). It focuses on acquiring, investing in, and managing secondary CLO mezzanine debt and equity tranches. The company relies on risk management, including disciplined liquidity management and selective use of credit hedges, to preserve book value during times. The company primary investment objectives are to generate attractive current yields and risk-adjusted total returns for shareholders. It invest in multiple parts of the CLO capital structure, principally mezzanine debt and equity tranches. Rather than focusing only on short-term current yield, it select investments that it believe will provide a strong total return to drive a sustainable earnings stream over a long-term horizon.